Characteristics of Patients with Graves’ Disease
| Study | Age at diagnosis (y) | Thyroid volume (mL) | Doppler | fT3 (pg/mL)* | TRAK (U/I) | Thyreostatics |
| 1 | 45 | 21 | Hyperperfused | 4.9 | 12.3 | 10 mg carbimazole |
| 2 | 21 | 47 | Hyperperfused | 11.2 | 8,331.7 | 60 mg carbimazole |
| 3 | 53 | 17 | Hyperperfused | 5.9 | 6.1 | 20 mg thiamazole |
↵* Range, 2.3–4.2.
fT3 = free triiodothyronine.